Search Results - "Wilfehrt, Helen M"

Real-World Effectiveness of Sipuleucel-T on Overall Survival in Men with Advanced Prostate Cancer Treated with Androgen Receptor-Targeting Agents by Hafron, Jason M., Wilfehrt, Helen M., Ferro, Christine, Harmon, Matt, Flanders, Scott C., McKay, Rana R.

“…Introduction The treatment landscape for metastatic castration-resistant prostate cancer (mCRPC) continues to evolve. Sipuleucel-T was the first immunotherapy…”
Get full text

Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials by Antonarakis, Emmanuel S, Subudhi, Sumit K, Pieczonka, Christopher M, Karsh, Lawrence I, Quinn, David I, Hafron, Jason M, Wilfehrt, Helen M, Harmon, Matthew, Sheikh, Nadeem A, Shore, Neal D, Petrylak, Daniel P

“…We present long-term outcomes from 2 randomized studies [STAMP (with abiraterone, NCT01487863) and STRIDE (with enzalutamide, NCT01981122)] that were performed…”
Get full text

A Retrospective Observational Analysis of Overall Survival with Sipuleucel-T in Medicare Beneficiaries Treated for Advanced Prostate Cancer by McKay, Rana R., Hafron, Jason M., Ferro, Christine, Wilfehrt, Helen M., Fitch, Kate, Flanders, Scott C., Fabrizio, Michael D., Schweizer, Michael T.

“…Introduction Since sipuleucel-T approval in 2010, the treatment landscape for metastatic castration-resistant prostate cancer (mCRPC) now includes the…”
Get full text

In data we trust: the role and utility of dialysis provider databases in the policy process by Krishnan, Mahesh, Wilfehrt, Helen M, Lacson, Jr, Eduardo

Get full text

Bladder function in female rats: effects of aging and pregnancy by Wilfehrt, Helen M., Carson, Culley C., Marson, Lesley

“…In vivo anesthetized cystometrograms and in vitro bladder tissue strip responses were examined in three groups of female rats: young virgins (3 month), older…”
Get full text